Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Hospital of diagnosis and probability to receive a curative treatment for oesophageal cancer.

Koëter M, van Steenbergen LN, Lemmens VE, Rutten HJ, Roukema JA, Wijnhoven BP, Nieuwenhuijzen GA.

Eur J Surg Oncol. 2014 Oct;40(10):1338-45. doi: 10.1016/j.ejso.2013.12.024. Epub 2014 Jan 18.

PMID:
24484779
2.

Determinants in decision making for curative treatment and survival in patients with resectable oesophageal cancer in the Netherlands: a population-based study.

Koëter M, van Steenbergen LN, Lemmens VE, Rutten HJ, Roukema JA, Nieuwenhuijzen GA.

Cancer Epidemiol. 2015 Dec;39(6):863-9. doi: 10.1016/j.canep.2015.10.007. Epub 2015 Nov 9.

PMID:
26651448
3.

Hospital of diagnosis and probability of having surgical treatment for resectable gastric cancer.

van Putten M, Verhoeven RH, van Sandick JW, Plukker JT, Lemmens VE, Wijnhoven BP, Nieuwenhuijzen GA.

Br J Surg. 2016 Feb;103(3):233-41. doi: 10.1002/bjs.10054. Epub 2015 Dec 1.

PMID:
26621158
4.

The role of socio-economic status in the decision making on diagnosis and treatment of oesophageal cancer in The Netherlands.

van Vliet EP, Eijkemans MJ, Steyerberg EW, Kuipers EJ, Tilanus HW, van der Gaast A, Siersema PD.

Br J Cancer. 2006 Nov 6;95(9):1180-5. Epub 2006 Oct 10.

5.

Racial disparities in esophageal cancer treatment and outcomes.

Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, McGinn TG, Wisnivesky JP.

Ann Surg Oncol. 2008 Mar;15(3):881-8. Epub 2007 Nov 7.

PMID:
17987341
6.

Hospital type- and volume-outcome relationships in esophageal cancer patients receiving non-surgical treatments.

Hsu PK, Chen HS, Wang BY, Wu SC, Liu CY, Shih CH, Liu CC.

World J Gastroenterol. 2015 Jan 28;21(4):1234-42. doi: 10.3748/wjg.v21.i4.1234.

7.

Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis.

Njei B, McCarty TR, Birk JW.

J Gastroenterol Hepatol. 2016 Jun;31(6):1141-6. doi: 10.1111/jgh.13289.

8.

Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario.

Simunovic M, Rempel E, Thériault ME, Coates A, Whelan T, Holowaty E, Langer B, Levine M.

Can J Surg. 2006 Aug;49(4):251-8.

9.

Recent trends and predictors of multimodality treatment for oesophageal, oesophagogastric junction, and gastric cancer: A Dutch cohort-study.

Trip AK, Stiekema J, Visser O, Dikken JL, Cats A, Boot H, van Sandick JW, Jansen EP, Verheij M.

Acta Oncol. 2015 Nov;54(10):1754-62. doi: 10.3109/0284186X.2015.1009638. Epub 2015 Mar 23.

PMID:
25797568
10.

The effect of socioeconomic status on staging and treatment decisions in esophageal cancer.

Bus P, Aarts MJ, Lemmens VE, van Oijen MG, Creemers GJ, Nieuwenhuijzen GA, van Baal JW, Siersema PD.

J Clin Gastroenterol. 2012 Nov-Dec;46(10):833-9. doi: 10.1097/MCG.0b013e31824e8ff8.

PMID:
22460163
11.

Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer.

Koppert LB, Lemmens VE, Coebergh JW, Steyerberg EW, Wijnhoven BP, Tilanus HW, Janssen-Heijnen ML.

Br J Surg. 2012 Dec;99(12):1693-700. doi: 10.1002/bjs.8952.

PMID:
23132417
12.

Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden.

Sundelöf M, Lagergren J, Ye W.

Eur J Cancer. 2008 Jul;44(11):1566-71. doi: 10.1016/j.ejca.2008.04.002. Epub 2008 Apr 22.

PMID:
18434132
13.

Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center.

Reynolds JV, Donohoe CL, McGillycuddy E, Ravi N, O'Toole D, O'Byrne K, Hollywood D.

J Thorac Cardiovasc Surg. 2012 May;143(5):1130-1137.e1. doi: 10.1016/j.jtcvs.2011.12.003. Epub 2012 Jan 11.

14.

Treatment and outcome of young patients with esophageal cancer in the Netherlands.

van Nistelrooij AM, van Steenbergen LN, Spaander MC, Tilanus HW, van Lanschot JJ, Lemmens VE, Wijnhoven BP.

J Surg Oncol. 2014 May;109(6):561-6. doi: 10.1002/jso.23533. Epub 2013 Dec 11.

PMID:
24338660
16.

Effects of preoperative chemoradiotherapy on postsurgical morbidity and mortality in cT3-4 +/- cM1lymph cancer of the oesophagus and gastro-oesophageal junction.

Hagry O, Coosemans W, De Leyn P, Nafteux P, Van Raemdonck D, Van Cutsem E, Hausterman K, Lerut T.

Eur J Cardiothorac Surg. 2003 Aug;24(2):179-86; discussion 186.

PMID:
12895604
17.

Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer.

van Putten M, Koëter M, van Laarhoven HWM, Lemmens VEPP, Siersema PD, Hulshof MCCM, Verhoeven RHA, Nieuwenhuijzen GAP.

Ann Surg. 2018 Feb;267(2):303-310. doi: 10.1097/SLA.0000000000002063.

PMID:
27811508
18.

Analysis of factors influencing long-term survival after surgical resection for oesophageal squamous cell carcinoma.

Kolh P, Honore P, Gielen JL, Degauque C, Azzam C, Legrand M, Jacquet N.

Acta Chir Belg. 1999 May-Jun;99(3):113-8.

PMID:
10427345
19.

Curative treatment for esophageal cancer: Vancouver Island Cancer Centre experience from 1993 to 1998.

Wilson KS, Wilson AG, Dewar GJ.

Can J Gastroenterol. 2002 Jun;16(6):361-8.

PMID:
12096299
20.

Better survival in patients with esophageal cancer after surgical treatment in university hospitals: a plea for performance by surgical oncologists.

Verhoef C, van de Weyer R, Schaapveld M, Bastiaannet E, Plukker JT.

Ann Surg Oncol. 2007 May;14(5):1678-87. Epub 2007 Feb 9.

Supplemental Content

Support Center